Twist Financial Statements From 2010 to 2024

TWST Stock  USD 46.40  4.17  9.87%   
Twist Bioscience financial statements provide useful quarterly and yearly information to potential Twist Bioscience Corp investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Twist Bioscience financial statements helps investors assess Twist Bioscience's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Twist Bioscience's valuation are summarized below:
Gross Profit
84.2 M
Profit Margin
(0.75)
Market Capitalization
2.5 B
Enterprise Value Revenue
7.3976
Revenue
295.2 M
There are currently one hundred twenty fundamental trend indicators for Twist Bioscience Corp that can be evaluated and compared over time across competition. All traders should double-check Twist Bioscience's current fundamentals against the performance from 2010 to 2024 and make sure the trends continue to evolve in the right direction.

Twist Bioscience Total Revenue

328.62 Million

Check Twist Bioscience financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Twist Bioscience's main balance sheet or income statement drivers, such as Tax Provision of 588 K, Net Interest Income of 16.1 M or Interest Income of 16.1 M, as well as many indicators such as Price To Sales Ratio of 7.96, Dividend Yield of 0.0 or PTB Ratio of 5.82. Twist financial statements analysis is a perfect complement when working with Twist Bioscience Valuation or Volatility modules.
  
Check out the analysis of Twist Bioscience Correlation against competitors.

Twist Bioscience Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets478.9 M614.3 M318.6 M
Slightly volatile
Short and Long Term Debt Total92.9 M85 M124.4 M
Slightly volatile
Other Current Liabilities21.9 M34.9 M13.5 M
Slightly volatile
Total Current Liabilities49 M71 M32.9 M
Slightly volatile
Other Liabilities65.5 K69 K483.6 K
Pretty Stable
Property Plant And Equipment Net98.6 M161.3 M65.2 M
Slightly volatile
Current Deferred RevenueM2.1 M7.9 M
Pretty Stable
Accounts Payable1.5 M1.6 M6.1 M
Slightly volatile
Cash200.2 M226.3 M132.1 M
Slightly volatile
Non Current Assets Total157.2 M267.5 M102 M
Slightly volatile
Non Currrent Assets Other5.3 M5.9 M3.4 M
Slightly volatile
Long Term Debt1.2 M1.3 M5.8 M
Slightly volatile
Cash And Short Term Investments271.7 M276.4 M184.9 M
Slightly volatile
Net Receivables23.8 M34.9 M14.8 M
Slightly volatile
Good Will103.6 M98.7 M27.2 M
Slightly volatile
Common Stock Shares Outstanding42.5 M58 M32.3 M
Slightly volatile
Long Term Debt Total1.2 M1.3 M92.4 M
Slightly volatile
Liabilities And Stockholders Equity478.9 M614.3 M318.6 M
Slightly volatile
Non Current Liabilities Total86.5 M70.6 M118.8 M
Slightly volatile
Capital SurpluseB1.9 B636.7 M
Slightly volatile
Inventory19.1 M24.1 M12.1 M
Slightly volatile
Other Current Assets8.9 M11.4 M5.8 M
Slightly volatile
Other Stockholder Equity889.7 M1.7 B545.8 M
Slightly volatile
Total Liabilities122.2 M141.6 M150.8 M
Pretty Stable
Property Plant And Equipment Gross248.8 M237 M80.3 M
Slightly volatile
Short and Long Term Debt1.3 M1.4 M2.3 M
Very volatile
Preferred Stock Total Equity228.9 M334.1 M220.6 M
Slightly volatile
Total Current Assets321.6 M346.8 M216.6 M
Slightly volatile
Non Current Liabilities Other386.6 K407 K5.8 M
Pretty Stable
Short Term Debt31.1 M29.6 M9.8 M
Slightly volatile
Intangible Assets18.4 M14.5 M11.6 M
Slightly volatile
Property Plant Equipment258.9 M246.5 M76 M
Slightly volatile
Net Working Capital299.8 M275.8 M188.7 M
Slightly volatile
Deferred Long Term LiabilitiesM3.3 M3.6 M
Slightly volatile
Capital Lease Obligations80.7 M85 M48.6 M
Slightly volatile

Twist Bioscience Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Interest Income16.1 M15.3 M3.8 M
Slightly volatile
Depreciation And Amortization33 M31.4 M10.2 M
Slightly volatile
Interest Expense27.6 K29 K618.9 K
Slightly volatile
Selling General Administrative124.4 M218.4 M82.2 M
Slightly volatile
Total Revenue328.6 M313 M94.5 M
Slightly volatile
Other Operating Expenses283.1 M533.8 M188.6 M
Slightly volatile
Research Development64 M90.9 M45.2 M
Slightly volatile
Cost Of Revenue188.6 M179.6 M63 M
Slightly volatile
Total Operating Expenses196.4 M354.2 M132.4 M
Slightly volatile
Reconciled Depreciation33 M31.4 M11.6 M
Slightly volatile
Selling And Marketing Expenses2.3 M3.3 M1.8 M
Slightly volatile
Non Recurring18 M20.2 M22.1 M
Slightly volatile

Twist Bioscience Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation28.3 M50.9 M17.6 M
Slightly volatile
Begin Period Cash Flow177.3 M289.3 M118.8 M
Slightly volatile
Other Cashflows From Financing Activities6.5 M6.9 M42.9 M
Slightly volatile
Depreciation33 M31.4 M11.3 M
Slightly volatile
Capital Expenditures4.8 M5.1 M15.9 M
Slightly volatile
Total Cash From Financing Activities6.5 M6.9 M109.8 M
Pretty Stable
End Period Cash Flow201.5 M229.1 M132.8 M
Slightly volatile
Change To Netincome99.4 M94.7 M29.1 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio7.968.37556.588
Slightly volatile
Days Sales Outstanding38.6740.70589.281
Slightly volatile
Stock Based Compensation To Revenue0.240.16270.2767
Slightly volatile
Capex To Depreciation0.150.16151.6593
Very volatile
EV To Sales7.537.923652.6975
Slightly volatile
Inventory Turnover6.797.46016.7102
Slightly volatile
Days Of Inventory On Hand58.8148.926863.8862
Slightly volatile
Payables Turnover11611020.1855
Slightly volatile
Sales General And Administrative To Revenue0.830.883.9317
Slightly volatile
Research And Ddevelopement To Revenue0.280.29033.6026
Slightly volatile
Capex To Revenue0.01540.01621.2306
Slightly volatile
Cash Per Share4.64.76424.7463
Slightly volatile
Days Payables Outstanding3.153.312262.9438
Slightly volatile
Income Quality0.290.30710.7654
Slightly volatile
Intangibles To Total Assets0.170.16330.0636
Slightly volatile
Net Debt To EBITDA0.80.79960.8007
Slightly volatile
Current Ratio7.284.88386.7272
Very volatile
Receivables Turnover9.428.9674.6438
Slightly volatile
Graham Number20.2725.681421.4468
Slightly volatile
Capex Per Share0.08310.08750.4253
Pretty Stable
Revenue Per Share5.665.39461.8945
Slightly volatile
Interest Debt Per Share0.360.25570.4316
Slightly volatile
Debt To Assets0.02630.02770.0829
Slightly volatile
Operating Cycle16989.6317158
Very volatile
Days Of Payables Outstanding3.153.312262.9438
Slightly volatile
Ebt Per Ebit1.10.94261.01
Very volatile
Quick Ratio6.934.54476.4597
Pretty Stable
Net Income Per E B T1.11.00271.0062
Pretty Stable
Cash Ratio3.03.18733.5481
Pretty Stable
Cash Conversion Cycle79.3286.319589.2227
Slightly volatile
Days Of Inventory Outstanding58.8148.926863.8862
Slightly volatile
Days Of Sales Outstanding38.6740.70589.281
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.971.07921.1796
Very volatile
Fixed Asset Turnover1.11.93970.9533
Slightly volatile
Debt Ratio0.02630.02770.0829
Slightly volatile
Price Sales Ratio7.968.37556.588
Slightly volatile
Asset Turnover0.530.50950.1864
Slightly volatile

Twist Bioscience Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap524.6 M590.2 M642.7 M
Slightly volatile
Enterprise Value493.4 M555.1 M604.5 M
Slightly volatile

Twist Fundamental Market Drivers

Cash And Short Term Investments276.4 M

Twist Upcoming Events

2nd of February 2024
Upcoming Quarterly Report
View
3rd of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
15th of November 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
30th of September 2023
Last Financial Announcement
View

About Twist Bioscience Financial Statements

Twist Bioscience shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Twist Bioscience investors may analyze each financial statement separately, they are all interrelated. The changes in Twist Bioscience's assets and liabilities, for example, are also reflected in the revenues and expenses on on Twist Bioscience's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue2.1 MM
Total Revenue313 M328.6 M
Cost Of Revenue179.6 M188.6 M
Stock Based Compensation To Revenue 0.16  0.24 
Sales General And Administrative To Revenue 0.88  0.83 
Research And Ddevelopement To Revenue 0.29  0.28 
Capex To Revenue 0.02  0.02 
Revenue Per Share 5.39  5.66 
Ebit Per Revenue(0.71)(0.74)

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Twist Stock Analysis

When running Twist Bioscience's price analysis, check to measure Twist Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Twist Bioscience is operating at the current time. Most of Twist Bioscience's value examination focuses on studying past and present price action to predict the probability of Twist Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Twist Bioscience's price. Additionally, you may evaluate how the addition of Twist Bioscience to your portfolios can decrease your overall portfolio volatility.